Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1485-1490

  Ten Klooster, Peter M ^a   Veehof, Martine M ^a   Taal, Erik ^a   Van Riel, Piet L C M ^b   Van De Laar, Mart A F J ^a,c  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HAND FUNCTION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RATING SCALE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WALKING; WORK;

ACTIVITIES OF DAILY LIVING; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; FEMALE; FOLLOW-UP STUDIES; HEALTH PRIORITIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35648940859     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.069765     Document Type: Article

References (37)

1. Anderson KO, Bradley LA, Young LD, McDaniel LK, Wise CM. Rheumatoid arthritis: review of psychological factors related to etiology, effects and treatment. Psychol Bull 1985;98:358-87.
2. Lapsley HM, March LM, Tribe KL, Cross MJ, Courtenay BG, Brooks PM. Living with rheumatoid arthritis: expenditures, health status and social impact on patients. Ann Rheum Dis 2002;61:818-21.
3. Meenan RF, Yelin EH, Nevitt M, Epstein WV. The impact of chronic disease: a sociomedical profile of rheumatoid arthritis. Arthritis Rheum 1981;24:544-9.
4. Yelin E, Lubeck D, Holman H, Epstein W. The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls. J Rheumatol 1987;14:710-17.
5. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619-26.
6. O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CR. Individual quality of life in patients undergoing hip replacement. Lancet 1992;339:1088-91.
7. Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum 2001;45:372-7.
8. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314: 1580-3.
9. Hewlett SA. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877-9.
10. Hewlett S, Smith AP, Kirwan JR. Values for function in rheumatoid arthritis: patients, professionals and public. Ann Rheum Dis 2001;60:928-33.
11. Archenholtz B, Bjelle A. Reliability, validity and sensitivity of a Swedish version of the revised and expanded Arthritis Impact Measurement Scales (AIMS2). J Rheumatol 1997;24:1370-7.
12. Gibson T, Clark B. Use of simple analgesics in rheumatoid arthritis. Ann Rheum Dis 1985;44:27-9.
13. Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002;47:391-7.
14. McKenna F, Wright V. Pain and rheumatoid arthritis. Ann Rheum Dis 1985;44:805.
15. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis Rheum 1992;35:1-10.
16. Minnock P, Fitzgerald O, Bresnihan B. Quality of life, social support and knowledge of disease in women with rheumatoid arthritis. Arthritis Rheum 2003;49:221-7.
17. Riemsma RP, Taal E, Rasker JJ, Houtman PM, van Paassen HC, Wiegman O. Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis. Br J Rheumatol 1996;35:755-60.
18. Taal E, Rasker JJ, Evers AW, Kraaimaat FW, Lanting PJH, Jacobs JW. Which priorities have rheumatoid arthritis (RA) patients for their health status improvement? (Abstract). Arthritis Rheum 1997;40(Suppl 1):S231-40.
19. Carr AJ, Higginson U. Are quality of life measures patient centred? BMJ 2001;322:1357-60.
20. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al. Rheumatology outcomes: the patient's perspective. J Rheumatol 2003;30:880-3.
21. Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis-progress at OMERACT 7. J Rheumatol 2005;32:2250-6.
22. Heiberg T, Finset A, Uhlig T, Kvien TK. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:191-5.
23. Boonen A, Landewe R. Health status in rheumatoid arthritis over 7 years. Ann Rheum Dis 2005;64:173-5.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified Disease Activity Scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
26. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
27. Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984;3:305-9.
28. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795-8.
29. Fransen J, van Halm VP, Nurmohamed MT, van Riel PL, de Ryck Y, Dijkmans BA. Validity of the rheumatoid arthritis disease activity index (RADAI) in a two year open label study with leflunomide. Ann Rheum Dis 2005;64(suppl 3):194.
30. Bland M. An introduction to medical statistics, 3rd ed. Oxford: Oxford University Press, 2000.
31. Steinbrocker O, Traeger CH, Battman RG. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
32. Chamberlain MA, Buchanan JM, Hanks H. The arthritic in an urban environment. Ann Rheum Dis 1979;38:51-6.
33. Cornelissen PG, Rasker JJ, Valkenburg HA. The arthritis sufferer and the community: a comparison of arthritis sufferers in rural and urban areas. Ann Rheum Dis 1988;47:150-6.
34. Taal E, Rasker JJ, Seydel ER, Wiegman O. Health status, adherence with health recommendations, self-efficacy and social support in patients with rheumatoid arthritis. Patient Educ Couns 1993;20:63-76.
35. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmen M, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol 2003;30:868-72.
36. Ahlmen M, Nordenskiold U, Archenholtz B, Thyberg I, Ronnqvist R, Linden L, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology (Oxford) 2005;44:105-10.
37. Hewlett S, Carr M, Ryan S, Kirwan J, Richards P, Carr A, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 2005;3:131-42.